fondazioneveronesi.it
Funds cancer research and provides prevention and health education in Italy
About fondazioneveronesi.it
Fondazione Umberto Veronesi supports scientific research into cancer and provides information on cancer prevention, diagnosis and treatment.
The foundation raises funds through donations, fundraising campaigns, charitable bequests and sales of solidarity gifts. It supports research projects, fellowships, care protocols and clinical registries.
Product: Cancer research funding and public health education.
Jobs at fondazioneveronesi.it
More biotech & pharma companies
abiogen.it
Develops, manufactures and markets pharmaceutical treatments for patients and healthcare providers in Italy and international marketsNew on Evolcarcangea.it
Italian manufacturer of herbal remedies and food supplements based on medicinal plants, sold to consumers and therapistsNew on EvolcCellply
Automated cell-therapy analysis platforms for biopharma companies and research institutesdulco.it
Dulco laxatives for constipation relief in sachets, solutions, tablets and suppositories, for consumers in ItalyNew on Evolcfarmagalenica.it
Galenic (magistral) drug compounding in partner Italian pharmacy labs, for patients, doctors and pharmacistsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Frontend frameworks
- NuxtHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- VueMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.